nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Aminosalicylic Acid—PTGS2—abdominal aortic aneurysm	0.0972	0.56	CrCbGaD
Droxidopa—Mesalazine—PTGS2—abdominal aortic aneurysm	0.0762	0.44	CrCbGaD
Droxidopa—ADRA1D—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00259	0.00313	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00257	0.00312	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.00256	0.0031	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00254	0.00307	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00252	0.00304	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.00251	0.00303	CbGpPWpGaD
Droxidopa—PAH—Disease—APOE—abdominal aortic aneurysm	0.0025	0.00302	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00248	0.003	CbGpPWpGaD
Droxidopa—ADRB3—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00248	0.003	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00242	0.00292	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00236	0.00286	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00236	0.00285	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00235	0.00284	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00235	0.00284	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00235	0.00284	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00234	0.00283	CbGpPWpGaD
Droxidopa—PAH—Disease—NOS2—abdominal aortic aneurysm	0.00233	0.00281	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00232	0.00281	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00231	0.0028	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00231	0.00279	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00229	0.00278	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00228	0.00276	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—AGT—abdominal aortic aneurysm	0.00222	0.00268	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00221	0.00267	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.0022	0.00266	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00218	0.00264	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00217	0.00263	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00215	0.0026	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00214	0.00259	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00214	0.00259	CbGpPWpGaD
Droxidopa—PAH—Metabolism—AGT—abdominal aortic aneurysm	0.00213	0.00258	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00213	0.00258	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00212	0.00257	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00212	0.00257	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00209	0.00253	CbGpPWpGaD
Droxidopa—PAH—Metabolism—APOE—abdominal aortic aneurysm	0.00209	0.00253	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00205	0.00249	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00198	0.0024	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00196	0.00237	CbGpPWpGaD
Droxidopa—PAH—Disease—SERPINE1—abdominal aortic aneurysm	0.00196	0.00237	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00196	0.00237	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00195	0.00236	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00193	0.00234	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00191	0.00232	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00191	0.00231	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00191	0.00231	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.0019	0.0023	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00189	0.00229	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.00179	0.00217	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00179	0.00216	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00179	0.00216	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.00177	0.00214	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00177	0.00214	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.00176	0.00213	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00176	0.00213	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00175	0.00211	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00173	0.0021	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00173	0.00209	CbGpPWpGaD
Droxidopa—PAH—Disease—PTGS2—abdominal aortic aneurysm	0.00171	0.00207	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.0017	0.00206	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00165	0.002	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00163	0.00197	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00161	0.00195	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00161	0.00195	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.00161	0.00195	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00157	0.00191	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00156	0.00189	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00154	0.00187	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00148	0.0018	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00147	0.00178	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00146	0.00176	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.00145	0.00176	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00145	0.00175	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—NOS2—abdominal aortic aneurysm	0.00145	0.00175	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00144	0.00174	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00143	0.00174	CbGpPWpGaD
Droxidopa—PAH—Metabolism—PTGS2—abdominal aortic aneurysm	0.00143	0.00173	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00143	0.00173	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00142	0.00172	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.0014	0.0017	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00139	0.00168	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AGT—abdominal aortic aneurysm	0.00138	0.00167	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00136	0.00165	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00135	0.00164	CbGpPWpGaD
Droxidopa—DDC—Metabolism—APOE—abdominal aortic aneurysm	0.00135	0.00164	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—NOS2—abdominal aortic aneurysm	0.00135	0.00163	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.00134	0.00162	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00134	0.00162	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00134	0.00162	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00133	0.00161	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00132	0.0016	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00131	0.00158	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.0013	0.00158	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AAAS—abdominal aortic aneurysm	0.0013	0.00157	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.0013	0.00157	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00129	0.00156	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00127	0.00154	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00127	0.00154	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.00127	0.00154	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00126	0.00153	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00125	0.00152	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00125	0.00151	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00124	0.0015	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00123	0.00149	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00122	0.00147	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00121	0.00146	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00119	0.00144	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00119	0.00144	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00117	0.00142	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00116	0.0014	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00116	0.0014	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00116	0.0014	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00115	0.00139	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00115	0.00139	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.00114	0.00138	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00114	0.00137	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—LDLR—abdominal aortic aneurysm	0.00113	0.00137	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00112	0.00136	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00111	0.00134	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.00111	0.00134	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—NOS2—abdominal aortic aneurysm	0.0011	0.00133	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00109	0.00132	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.00108	0.0013	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00107	0.0013	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00106	0.00128	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AAAS—abdominal aortic aneurysm	0.00106	0.00128	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.00105	0.00128	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00105	0.00127	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00102	0.00124	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00102	0.00124	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00102	0.00123	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00102	0.00123	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00101	0.00122	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.00101	0.00122	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.001	0.00121	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.001	0.00121	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000988	0.00119	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000979	0.00119	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000959	0.00116	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000951	0.00115	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00095	0.00115	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000948	0.00115	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.00094	0.00114	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000938	0.00113	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000934	0.00113	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000933	0.00113	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—abdominal aortic aneurysm	0.000926	0.00112	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000923	0.00112	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—LDLR—abdominal aortic aneurysm	0.000921	0.00111	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.00092	0.00111	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000917	0.00111	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000912	0.0011	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000908	0.0011	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000897	0.00109	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000894	0.00108	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000887	0.00107	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000873	0.00106	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000873	0.00106	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000849	0.00103	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000845	0.00102	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000835	0.00101	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000829	0.001	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000829	0.001	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000817	0.000988	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000776	0.000938	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00077	0.000932	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.00077	0.000931	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000763	0.000923	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000759	0.000918	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000755	0.000914	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000753	0.000911	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000753	0.000911	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000752	0.000909	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000748	0.000905	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000742	0.000897	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000739	0.000894	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000721	0.000872	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000712	0.000862	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000702	0.000849	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000701	0.000848	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000699	0.000846	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000689	0.000834	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000688	0.000832	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000686	0.00083	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00068	0.000822	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000671	0.000812	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000635	0.000768	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000625	0.000756	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000623	0.000753	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000611	0.000739	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AGT—abdominal aortic aneurysm	0.0006	0.000725	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000594	0.000719	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—APOE—abdominal aortic aneurysm	0.000587	0.000711	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000582	0.000705	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000579	0.0007	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000568	0.000687	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000555	0.000672	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000542	0.000655	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000537	0.00065	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000537	0.000649	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000532	0.000643	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000531	0.000642	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00053	0.000641	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000526	0.000636	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000519	0.000628	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000516	0.000624	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000501	0.000606	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000493	0.000597	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000491	0.000594	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00049	0.000592	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AGT—abdominal aortic aneurysm	0.000487	0.000589	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000483	0.000585	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—APOE—abdominal aortic aneurysm	0.000477	0.000577	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000457	0.000553	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000446	0.00054	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000442	0.000535	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000438	0.00053	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000436	0.000528	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000429	0.000519	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000416	0.000504	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000413	0.000499	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000413	0.000499	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000407	0.000493	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000407	0.000493	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000406	0.000492	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—abdominal aortic aneurysm	0.000402	0.000487	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000399	0.000483	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000385	0.000466	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000379	0.000459	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000361	0.000437	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00035	0.000424	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000346	0.000419	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000337	0.000408	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000335	0.000406	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—abdominal aortic aneurysm	0.000327	0.000396	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000319	0.000386	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000316	0.000382	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000316	0.000382	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000313	0.000379	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000313	0.000378	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000312	0.000377	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000309	0.000373	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000295	0.000357	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000292	0.000353	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000291	0.000352	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000287	0.000348	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000258	0.000312	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000255	0.000309	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00024	0.00029	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000237	0.000287	CbGpPWpGaD
